Researchers build on a breakthrough in treating Muscular Dystrophy

U of A team identifies a peptide additive that improves the effect of existing genetic therapies for the most common type of the neuromuscular disease.

U of A team identifies a peptide additive that improves the effect of existing genetic therapies for the most common type of the neuromuscular disease.